FTC's Campaign Against Improper Orange Book Listings Continues With Amicus Brief In Teva's Challenge Of Amneal Asthma Inhaler ANDA - Antitrust, EU Competition
The Federal Trade Commission ("FTC") has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC to further the agency's...
Takeda Pharm Amneal Pharmaceuticals Of New York Commission Statement Concerning Brand Drug Manufacturers Welfare Fund Teva Branded Pharmaceuticals Products Federal Trade Commission
Source: mondaq.com